癌症类型和组织学影响皮肤免疫疗法毒性:一个多机构队列研究
Guihong Wan1,2, Sara Khattab1, Bonnie W Leung1,3,4
1Department of Dermatology, Massachusetts General Hospital, Boston, MA.
The British journal of dermatology
|February 17, 2024
概括
接受免疫检查点抑制剂 (ICI) 治疗的皮肤恶性瘤患者面临皮肤免疫相关不良事件 (cirAEs) 的更高风险. 这种增加的风险与改善的生存结果有关,强调需要更密切的监测.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 皮肤免疫相关不良事件 (cirAEs) 是与免疫检查点抑制剂 (ICI) 治疗相关的常见毒性.
- 识别患有cirAEs风险较高的患者可以改善治疗结果和生活质量.
研究的目的:
- 检查癌症类型和组织学如何影响接受ICI治疗的患者中cirAEs的发展.
- 研究cirAEs对ICI治疗患者的生存结果的影响.
主要方法:
- 在2011年至2020年期间接受ICI治疗的3668名患者的回顾性队列研究.
- 使用多变量Cox比例危险模型,根据癌症类型和组织学评估基于癌症类型和组织学评估cirAEs的风险,并对共变量进行调整.
- 时间变化的考克斯模型分析了cirAE发展对死亡率的影响.
主要成果:
- 皮肤状细胞癌 (cSCC) 和黑色素瘤显示出明显更高的cirAEs风险 (HR分别为3.57和2.09).
- 其他癌症与增加的cirAE风险包括头部和部腺癌,以及生殖尿路过渡细胞癌和腺癌.
- 发育cirAEs与改善黑色素瘤 (HR 0.37) 和cSCC (HR 0.51) 的存活率有关.
结论:
- 用ICI疗法治疗的皮肤恶性瘤患者经历了最高的CiraEs率和相关的生存益处.
- 这项研究提高了对cirAEs患者风险的理解,为瘤学家和皮肤病学家提供了有针对性的监测和咨询.
- 研究的局限性包括其回顾性设计和单个地理位置的队列.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


